The period for CME/CE credit for this activity has expired.

Insomnia

Redefining Insomnia: State-of-the-Science in Insomnia Management

INSTRUCTIONS

Applied Practical Learning (APL) is intended to assess behavioral change as a result of participating in a continuing education activity. There are 2 sections in this activity. Both sections must be completed to receive credit.

After completing both sections and submitting them as directed, a continuing education certificate will automatically be generated and should be printed or saved to your computer for your records.

Thank you for your participation.

Redefining Insomnia: State-of-the-Science Insomnia Management – Applied Practical Learning Component

Term of Approval

Release Date: January 2008

Expiration Date: January 31, 2009

Program Overview

As many as one-third of adults in the United States suffer from insomnia, which has been linked to increased work absence, decreased job performance, and decreased life expectancy. Nearly 10% describe their insomnia as serious or chronic. Insomnia is also implicated in motor function and cognitive impairment, increased body mass index, and increased insulin resistance. Despite those grave consequences and a high prevalence, insomnia is often not perceived as a condition serious enough to warrant a physician visit. The perception that insomnia is somehow benign results in low treatment rates among patients who suffer from this sleep disorder either by itself or as a comorbid condition. The National Institutes of Health (NIH) State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults provides guidelines for the diagnosis and treatment of acute and chronic insomnia. This activity will assess recommendations for appropriate management of patients with this disorder.

Intended Audience

This activity was developed for primary care physicians, psychiatrists, pharmacists, and other healthcare professionals involved in the management of patients with chronic insomnia.

Method of Participation and Obtaining CME Credit

CME credit is offered upon successful completion of the posttest. Certificates will be issued to participants after completion and receipt of the CME Demographic and Evaluation Form and successful completion of the posttest with a passing score of 70% or higher.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

•  Understand the recommendations for current practice found in the National Institutes of Health State-of-the-Science Conference Statement on Manifestations and Management of Chronic Insomnia

•  Define normal sleep, insomnia, and insomnia consequences

•  Identify comorbidities and risk factors for chronic insomnia

•  Describe approaches to diagnosis and assessment

•  Analyze non-pharmacologic and pharmacologic interventions for managing chronic insomnia

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Summit Institute of Knowledge, Inc. ( Summit ) and International Medical Press (IMP). Summit is accredited by the ACCME to provide continuing medical education for physicians.

ACPE Logo Summit is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

 

Credit Designation Statements

Summit designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity will provide 1.0 hours (0.1 CEUs) of credit. The ACPE Universal Program Number is 442-9999-07-002-H01P.

Disclosures

In compliance with the ACCME and the ACPE, it is the policy of Summit and IMP to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All individuals involved in planning (eg, CME provider staff, faculty, and planners) are expected to disclose any significant financial relationships with commercial interests over the past 12 months . Summit also requires that faculty identify and reference off-label product or investigational uses of pharmaceutical and medical device products.

All conflicts of interest have been mitigated and resolved through the use of a peer review process.

FACULTY

Dipak V. Vashi , MD

Speakers Bureau: Boehringer Ingelheim; Novartis; sanofi-aventis

CME PROVIDER AND EDUCATIONAL PARTNER STAFF

All staff of Summit and IMP in a position to influence content have filed statements of disclosure with the CME provider. Any conflicts of interest were identified and resolved prior to their involvement in planning this activity. These disclosures are available for review by contacting Amy Groves at 1 404 443 1596 or e-mail at amy.groves@intmedpress.com.

Summit and IMP staff have disclosed no conflicts of interest.

Disclaimer

This activity is designed for healthcare professionals for educational purposes. Information and opinions offered by the faculty represent their own viewpoints. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information.

While Summit makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participants should use their clinical judgment, knowledge, experience and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Commercial Support Acknowledgment

This activity is supported by an educational grant from sanofi-aventis.

Applied Practical Learning (APL) Section

  • PLEASE NOTE: You can click on each section to get a look at this activity but you must be signed in to participate and receive CME credit. New to WebBasedCME.com? Click here to register.
  •  
  • Demographic Questionnaire - This portion of the activity allows us to evaluate the types of healthcare professionals who are participating in the activity. This information will also be used to develop needs assessments for future educational programs on this topic. Thus, to the best of your ability, please respond with what you feel is the most accurate answer. After completing this section, you will be directed to the patient case study section.
  •  
  • Patient Case Study (APL) - This portion of the activity will help us determine how you will apply the information used in the CME activity to your clinical practice by presenting a hypothetical patient and asking questions about your treatment approach for this patient. When answering these questions, please try to relate the patient to a specific patient in your practice with the same characteristics.